Ads

 

Ads

 

Ads

 

World Top 1,000 Companies as of January 2024

World Top 1,000 Companies by Market Cap as of January 2024 from Value.Today

World Top 1,000 Companies by Market Cap as of Jan-05-2024. World Biggest 1,000 Companies by Market Cap as of Jan-05-2024. In 2024 also Apple retained World 1st Rank by Market Cap. Second position is occupied by Microsoft. USA companies got First and second rank positions. Third position is occupied by Saudi Aramco from Saudi Arabia.

World Top 1,000 Companies market cap or net worth as of Jan-05-2024 was 77.29 Trillion USD. Both listed and unlisted companies data is considered.

NRW Holdings

World Rank (Jan-05-2024)
9,286
Market Cap (Jan-05-2024)
0.878 Billion USD
World Rank (Jul-30-2023)
9,890
Market Cap (Jul-30-2023)
0.804 Billion USD
World Rank (Dec-25-2022)
9,158
Market Cap (Dec-25-2022)
0.864 Billion USD
World Rank (Jan-07-2022)
12,627
Market Cap (Jan-07-2022)
0.57 Billion USD
Annual Revenue in USD
1,646 Million USD
Annual Net Income in USD
67 Million USD
Annual Results for Period Ending
Jun-2022 ending year
Headquarters Country

Data#3 Limited

World Rank (Jan-05-2024)
9,287
Market Cap (Jan-05-2024)
0.878 Billion USD
World Rank (Jul-30-2023)
10,098
Market Cap (Jul-30-2023)
0.775 Billion USD
World Rank (Dec-25-2022)
10,307
Market Cap (Dec-25-2022)
0.706 Billion USD
World Rank (Jan-07-2022)
11,956
Market Cap (Jan-07-2022)
0.64 Billion USD
Annual Revenue in USD
1,517 Million USD
Annual Net Income in USD
21 Million USD
Annual Results for Period Ending
Jun-2022 ending year
Headquarters Country

Prime Medicine Inc.

World Rank (Jan-05-2024)
9,288
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
7,043
Market Cap (Jul-30-2023)
1.443 Billion USD
World Rank (Dec-25-2022)
5,955
Market Cap (Dec-25-2022)
1.733 Billion USD
Headquarters Country
Company Profile
PRIME MEDICINE, INC. is a biotechnology company. It delivers genetic therapies to address diseases by deploying gene editing technology. PRIME MEDICINE, INC. offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme, and a pegRNA. Headquarters is in USA.

Lingyuan Iron & Steel Co. Ltd

World Rank (Jan-05-2024)
9,289
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
8,673
Market Cap (Jul-30-2023)
1.013 Billion USD
World Rank (Dec-25-2022)
9,007
Market Cap (Dec-25-2022)
0.886 Billion USD
World Rank (Jan-07-2022)
8,237
Market Cap (Jan-07-2022)
1.26 Billion USD
Headquarters Country

Komeda Holdings

World Rank (Jan-05-2024)
9,290
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
9,346
Market Cap (Jul-30-2023)
0.889 Billion USD
World Rank (Dec-25-2022)
9,243
Market Cap (Dec-25-2022)
0.851 Billion USD
World Rank (Jan-07-2022)
10,602
Market Cap (Jan-07-2022)
0.81 Billion USD
Annual Revenue in USD
243 Million USD
Annual Net Income in USD
36 Million USD
Annual Results for Period Ending
Feb-2022 ending year
Headquarters Country

Shenzhen Topraysolar

World Rank (Jan-05-2024)
9,291
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
9,109
Market Cap (Jul-30-2023)
0.929 Billion USD
World Rank (Dec-25-2022)
8,751
Market Cap (Dec-25-2022)
0.928 Billion USD
World Rank (Jan-07-2022)
7,669
Market Cap (Jan-07-2022)
1.42 Billion USD
Headquarters Country

GB Group

World Rank (Jan-05-2024)
9,292
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
9,751
Market Cap (Jul-30-2023)
0.824 Billion USD
World Rank (Dec-25-2022)
8,452
Market Cap (Dec-25-2022)
0.982 Billion USD
World Rank (Jan-07-2022)
5,649
Market Cap (Jan-07-2022)
2.36 Billion USD
Annual Revenue in USD
285 Million USD
Annual Net Income in USD
18 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile
GB Group is a Identity Management Verification Solutions company. It has 20,000 organizations create simple and secure digital experiences for their customers around the world and has more than 1,000 employees. Total Revenue as per 2020 is 199.10(£m). Net Profit as per 2020 is 17.06(£m). Total Assets as per 2020 is 526.20(£m). Total Liabilities as per 2020 is 181.27(£m). The headquarters is in UK.

Net263

World Rank (Jan-05-2024)
9,293
Market Cap (Jan-05-2024)
0.876 Billion USD
World Rank (Jul-30-2023)
9,211
Market Cap (Jul-30-2023)
0.911 Billion USD
World Rank (Dec-25-2022)
8,472
Market Cap (Dec-25-2022)
0.978 Billion USD
World Rank (Jan-07-2022)
9,347
Market Cap (Jan-07-2022)
1.02 Billion USD
Headquarters Country

AllianceBernstein Global High Income Fund

World Rank (Jan-05-2024)
9,294
Market Cap (Jan-05-2024)
0.876 Billion USD
World Rank (Jul-30-2023)
9,558
Market Cap (Jul-30-2023)
0.853 Billion USD
World Rank (Dec-25-2022)
9,466
Market Cap (Dec-25-2022)
0.819 Billion USD
World Rank (Jan-07-2022)
9,206
Market Cap (Jan-07-2022)
1.04 Billion USD
Annual Revenue in USD
3 Million USD
Annual Net Income in USD
2 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country

Kaken Pharmaceutical

World Rank (Jan-05-2024)
9,295
Market Cap (Jan-05-2024)
0.876 Billion USD
World Rank (Jul-30-2023)
9,106
Market Cap (Jul-30-2023)
0.929 Billion USD
World Rank (Dec-25-2022)
7,932
Market Cap (Dec-25-2022)
1.098 Billion USD
World Rank (Jan-07-2022)
7,872
Market Cap (Jan-07-2022)
1.36 Billion USD
Annual Revenue in USD
555 Million USD
Annual Net Income in USD
70 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile
Kaken Pharmaceutical is a specialty pharmaceutical company with strong experience in developing and commercializing novel pharmaceuticals and medical devices in the fields of orthopaedics and dermatology. The company annual revenue is 76,034 million JPY and annual net income is 9,549 million JPY for year ending March 2022. The headquarters is in Japan.

Share

Ads